Hematological conditions treated in IHBT

Hematological conditions treated in IHBT:

• Acute myeloid leukemia
• Acute lymphoblastic leukemia
• Acute promyelocytic leukemia
• Myelodysplastic syndromes
• Chronic myeloid leukemia
• Chronic lymphocytic leukemia
• Ph-negative myeloproliferative disorders (polycythemia vera, primary myelofibrosis, essential thrombocythemia)
• Myelodysplastic/myeloproliferative diseases (chronic myelomonocytic leukemia)
  Mast cell and eosinophils´disease (hypereosinophilic syndrome, systemic mastocytosis)
• Thrombotic thrombocytopenic purpura
• Idiopathic thrombocytopenic purpura
• Disseminated intravascular coagulation
• Thrombotic disorders inherited or acquired
• Bleeding disorders inherited or acquired (hemophilia A (factor VIII deficiency), hemophilia B (factor IX deficiency), von Willebrand disease, and rare factor deficiencies)
• Hemolytic anemia inherited or acquired
• Paroxysmal nocturnal hemoglobinuria
• Rare red blood cells disorders (hemoglobinopathies, thalassemia…)
• Bone marrow failure syndromes
• Aplastic anemia
• Graft versus Host Disease
• Infectious complications of hematological treatment
  • Invasive mycosis
  • CMV reactivation
  • Febrile neutropenia
• Sepsis

Specialized treatment methods performed at IHTB:

• Allogeneic stem cell transplantation
• CAR-T cell therapy (acute lymphoblastic leukemia, Non-Hodgkin's lymphoma)
• extracorporeal photopheresis, plasmapheresis, immunoadsorption